ABL1 and Parkinson disease: One additional target for c-Abl deserving to be mentioned here is the cyclin-dependent kinase 5 (Cdk5) that is highly expressed in brain neurons and shown to be activated in neurodegenerative diseases including PD (Smith et al., 2003; Wen et al., 2014).